We talk about ML and AI quite a bit on this show. Our angle is always to avoid the hype and help you find the practical applications that you can put to work right now. Today’s episode is a great extension of this ongoing conversation. We talk with Dr. Taha Kass-Hout, Chief Medical Officer and Director, Machine Learning at Amazon Web Services about how they are trying to bring ML to the masses. We discuss:

  • What’s needed to use machine learning at scale with cost efficiency, performance, and accountability.
  • The challenges in analyzing healthcare’s largely unstructured data.
  • The practicality of bringing AI/ML capabilities directly to the hospitals, health systems, medical offices, etc.
  • How should CIOs and other buyers evaluate ML solutions? How can they tell what is real and what is hype?
  • Detecting bias, drift in models, and drift in data in machine learning.
  • Tooling for privacy, security, and compliance.
  • The importance of owning and controlling your own data.
  • The problems caused by bad training data

Dr. Taha Kass-Hout

Dr. Taha Kass-Hout, M.D., M.S., is the Chief Medical Officer and Director, Machine Learning, Amazon Web Services, and leads our Health AI strategy and efforts, including Amazon Comprehend Medical and Amazon HealthLake. He works with teams at Amazon responsible for developing the science, technology, and scale for COVID-19 lab testing, including Amazon’s first FDA authorization for testing our associates—now offered to the public for at-home testing. A physician and bioinformatician, Taha served two terms under President Obama, including the first Chief Health Informatics officer at the FDA. During this time as a public servant, he pioneered the use of emerging technologies and the cloud (the CDC’s electronic disease surveillance), and established widely accessible global data sharing platforms: the openFDA, which enabled researchers and the public to search and analyze adverse event data, and precisionFDA (part of the Presidential Precision Medicine initiative). Taha holds doctor of medicine and master of science in biostatistics degrees from the University of Texas and completed clinical training at Harvard Medical School’s Beth Israel Deaconess Medical Center.

About AWS Healthcare, Life Sciences, and Genomics

AWS is helping healthcare, life sciences, and genomics customers around the world transform the way they conduct research, develop products, and enhance the patient experience. AWS currently works with many customers, ranging from small, independent labs and clinics, to researchers, device manufacturers, Fortune 500 companies, and government entities such as Ontario Health, UC San Diego Health, MetroPlus Health Plan, Moderna, Cerner, Philips, and Novartis as well as the industry’s newest innovators such as Halodoc, Lyell Therapeutics, Butterfly IQ, aidoc, Bluedot, and BenevolentAI. AWS offers over 130 HIPAA-eligible services, deep domain expertise, complete industry-specific offerings, access to a vast network of partners, and the security and privacy required by this highly regulated industry to help improve patient care, advance precision medicine, and bring new therapeutics to market faster.

Links and resources

Related Episodes

Listen to the interview right here:

Or, find it on your favorite podcast network such as:

Trying to drive change within your healthcare organization? Launching a new product? Having trouble getting decision-makers’ attention and buy-in?

We’ll help you understand the whole picture so that you can align your innovation with the things decision-makers care about. And then we’ll help you execute It’s not easy, but it’s possible and we’ll help you get there.  Sign up here and we’ll keep you up to date on healthcare industry news with podcasts, blog posts, conference announcements and more. No fluff. No hype. Just the valuable (and often not-so-obvious) information you need to get things done.

The #HCBiz Show! is produced by Glide Health IT, LLC in partnership with Netspective Media.

Music by StudioEtar